CTLA4 and neoplasm: For example, Kim et al. demonstrated that local ipsilateral injection of a F127/PEG hydrogel loaded with aPD-1 and anti-CTLA-4 significantly increased antibody retention at the injection site and reduced both tumor burden and liver toxicity compared to bolus delivery in a murine breast cancer model [256].